The Indiana Horse Racing Commission has terminated its contract with Truesdail Laboratory after the regulator says the Tustin, Calif., facility failed to report positive findings in three samples
Delays at the respected Lexington drug-testing laboratory LGC have forced two of its biggest customers, the Indiana Horse Racing Commission and Kentucky Horse Racing Commission, to consider other options.
A backlog at its primary laboratory has led the Indiana Horse Racing Commission to contract with second lab on an emergency basis.
The Horseracing Testing Laboratory Committee of the Racing Medication and Testing Consortium has approved full accreditation of three laboratories, it announced April 30.
The National HBPA and its affiliates said they have "zero tolerance" for trainers who use illegal Class 1 and Class 2 substances in racehorses in the wake of about 30 positives for Dermorphin in the Southwest.
A human drug used to treat high blood pressure, Attention Deficit Hyperactivity Disorder, and addictive behavior has been detected in at least 10 post-race samples of horses racing in Nebraska recently, and sources say the number of positive tests could double in the coming weeks. Seven trainers have been notified by the Nebraska Racing Commission that their horses tested positive for Clonidine, which drug testing experts say can have both a calming and analgesic effect on horses and is closely related to Romifidine and Guanabenz, two drugs suspected by racing officials as being used illegally on horses.
Most Popular Stories
- Barretts' First Del Mar Sale Sees Increase
- The Truth Or Else Joins Belmont Stakes Mix
- Smooth Stride Could Lift American Pharoah
- Secretariat's Birthplace Named 'Historic'
- Lopez Family Faces Off at Golden Gate
- Old Friends Cabin Creek Welcomes Be Bullish
- American Pharoah Jogs One Mile at Churchill
- Miss Temple City on Schedule for Royal Ascot
- No Belmont Stakes for Conquest Curlinate
- MarketWatch: McPeek on Yearling Selection